Literature DB >> 24931618

Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytes.

Yasutaka Ueda1, Jun-ichi Nishimura, Yoshiko Murakami, Sachiko Kajigaya, Taroh Kinoshita, Yuzuru Kanakura, Neal S Young.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired bone marrow disorder caused by expansion of a clone of hematopoietic cells lacking glycosylphosphatidylinositol (GPI)-anchored membrane proteins. Multiple lines of evidence suggest immune attack on normal hematopoietic stem cells provides a selective growth advantage to PNH clones. Recently, frequent loss of HLA alleles associated with copy number-neutral loss of heterozygosity in chromosome 6p (CN-6pLOH) in aplastic anemia (AA) patients was reported, suggesting that AA hematopoiesis 'escaped' from immune attack by loss of HLA alleles. We report here the first case of CN-6pLOH in a Japanese PNH patient only in GPI-anchored protein positive (59%) granulocytes, but not in GPI-anchored protein negative (41%) granulocytes. CN-6pLOH resulted in loss of the alleles A*02:06-DRB1*15:01-DQB1*06:02, which have been reported to be dominant in Japanese PNH patients. Our patient had maintained nearly normal blood count for several years. Our case supports the hypothesis that a hostile immune environment drives selection of resistant hematopoietic cell clones and indicates that clonal evolution may occur also in normal phenotype (non-PNH) cells in some cases.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  array comparative genomic hybridization; bone marrow failure syndromes; clonal evolution; loss of heterozygosity; paroxysmal nocturnal hemoglobinuria

Mesh:

Substances:

Year:  2014        PMID: 24931618      PMCID: PMC4060154          DOI: 10.1111/ejh.12253

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  13 in total

1.  Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.

Authors:  D J Araten; K Nafa; K Pakdeesuwan; L Luzzatto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

3.  The frequency of HLA class I alleles in Japanese patients with bone marrow failure.

Authors:  Tsutomu Shichishima; Hideyoshi Noji; Kazuhiko Ikeda; Kazuko Akutsu; Yukio Maruyama
Journal:  Haematologica       Date:  2006-05-16       Impact factor: 9.941

4.  Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.

Authors:  Nobuyoshi Hanaoka; Tatsuya Kawaguchi; Kentaro Horikawa; Shoichi Nagakura; Hiroaki Mitsuya; Hideki Nakakuma
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

Review 5.  The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria.

Authors:  A Karadimitris; L Luzzatto
Journal:  Leukemia       Date:  2001-08       Impact factor: 11.528

6.  Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro.

Authors:  Shoichi Nagakura; Sonoko Ishihara; Daniel E Dunn; Jun-ichi Nishimura; Tatsuya Kawaguchi; Kentaro Horikawa; Michihiro Hidaka; Tadashi Kagimoto; Nozomu Eto; Hiroaki Mitsuya; Taroh Kinoshita; Neal S Young; Hideki Nakakuma
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

7.  Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria.

Authors:  Lucia Gargiulo; Maria Papaioannou; Michela Sica; Giulia Talini; Aristeidis Chaidos; Barbara Richichi; Andrei V Nikolaev; Cristina Nativi; Mark Layton; Josu de la Fuente; Irene Roberts; Lucio Luzzatto; Rosario Notaro; Anastasios Karadimitris
Journal:  Blood       Date:  2013-01-31       Impact factor: 22.113

8.  HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Tsutomu Shichishima; Masatoshi Okamoto; Kazuhiko Ikeda; Toshihiko Kaneshige; Haruo Sugiyama; Takashi Terasawa; Kazuoki Osumi; Yukio Maruyama
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

9.  Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria.

Authors:  Yoshiko Murakami; Hiroshi Kosaka; Yusuke Maeda; Jun-ichi Nishimura; Norimitsu Inoue; Kazuhito Ohishi; Masaru Okabe; Junji Takeda; Taroh Kinoshita
Journal:  Blood       Date:  2002-07-18       Impact factor: 22.113

10.  Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

Authors:  J Takeda; T Miyata; K Kawagoe; Y Iida; Y Endo; T Fujita; M Takahashi; T Kitani; T Kinoshita
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

View more
  3 in total

1.  Clonality in context: hematopoietic clones in their marrow environment.

Authors:  James N Cooper; Neal S Young
Journal:  Blood       Date:  2017-10-18       Impact factor: 22.113

2.  Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

Authors:  Lova Sun; Daria V Babushok
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

3.  [Study on the loss of HLA-A allele expression in patients with aplastic anemia].

Authors:  H Q Zhang; H Q Wang; W W Qi; C Y Liu; L M Xing; R Fu; Z H Shao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.